Answers are grounded in this paper and cite their sources.
Delayed platelet engraftment is related to poor clinical outcome after autologous hematopoietic stem cell transplantation (ASCT). To analyze the related determinants we developed a mathematical model of human thrombopoiesis. The model is given by nonlinear ordinary differential equations (ODEs) simulating platelet production through seven maturation stages. It incorporates key biological processes (division, self-renewal, and differentiation of immature cell types) and the regulation of cellular kinetics by nonlinear feedback mechanisms. A higher transfused CD34 + cell dose was related to faster platelet engraftment. The model further suggests that not the total CD34 + number, but the abundance of common myeloid progenitors (CMPs) and megakaryocyte-erythroid progenitors (MEPs) in the CD34 + graft is linked to timely platelet engraftment. In conclusion, assessment of the CMP and MEP capacity within the CD34 + population before ASCT could help anticipate the risk of delayed platelet engraftment and increasing the abundance and proliferation of CMP and MEP might improve platelet engraftment after ASCT.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: